Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
Preformed Line Products
PLPC
$1.39B
| $624K | ﹤0.01% |
1,533
+27
| +2% | +$10.6K |
2013 Q2
53 quarters
|
|
3527
CALL
Marathon Digital Holdings
MARA
$2.65B
| $623K | ﹤0.01% |
55,000
-836,400
| -94% | -$9.6M |
2025 Q1
6 quarters
|
|
3528
Commercial Bancgroup
CBK
$460M
| $621K | ﹤0.01% |
19,801
+12,234
| +162% | +$412K |
2025 Q4
3 quarters
|
|
3529
IsoEnergy Ltd
ISOU
$527M
| $621K | ﹤0.01% |
69,611
-40,568
| -37% | -$417K |
2026 Q1
2 quarters
|
|
3530
CALL
Denali Therapeutics
DNLI
$3.35B
| $620K | ﹤0.01% |
+30,000
| New | +$702K |
2026 Q3
0 quarters
|
|
|
3531
PUT
Denali Therapeutics
DNLI
$3.35B
| $620K | ﹤0.01% |
+30,000
| New | +$702K |
2026 Q3
0 quarters
|
|
3532
iShares USD Green Bond ETF
BGRN
$495M
| $619K | ﹤0.01% |
13,576
+1,396
| +11% | +$65.2K |
2025 Q1
6 quarters
|
|
3533
iShares US Basic Materials ETF
IYM
$1.29B
| $619K | ﹤0.01% |
3,476
-193
| -5% | -$35.5K |
2013 Q2
53 quarters
|
|
3534
Happen Inc
HAPN
$1.92B
| $618K | ﹤0.01% |
41,792
-46,681
| -53% | -$851K |
2014 Q4
47 quarters
|
|
3535
Outfront Media
OUT
$5.72B
| $616K | ﹤0.01% |
22,212
-71,314
| -76% | -$2.18M |
2014 Q2
49 quarters
|
|
3536
Select Water Solutions
WTTR
$2.18B
| $615K | ﹤0.01% |
31,086
-169,688
| -85% | -$3.37M |
2017 Q4
35 quarters
|
|
3537
LG Display
LPL
$2.65B
| $615K | ﹤0.01% |
208,531
-175,559
| -46% | -$574K |
2018 Q4
31 quarters
|
|
3538
Schrodinger
SDGR
$2.13B
| $614K | ﹤0.01% |
19,790
-21,810
| -52% | -$430K |
2020 Q1
26 quarters
|
|
3539
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.89B
| $614K | ﹤0.01% |
11,523
+5,748
| +100% | +$316K |
2024 Q2
9 quarters
|
|
3540
Hess Midstream
HESM
$4.08B
| $612K | ﹤0.01% |
16,376
-68,108
| -81% | -$2.7M |
2020 Q2
25 quarters
|
|
3541
iShares Floating Rate Bond ETF
FLOT
$11.6B
| $612K | ﹤0.01% |
11,980
+8,236
| +220% | +$420K |
2013 Q2
53 quarters
|
|
3542
Rapport Therapeutics
RAPP
$1.46B
| $611K | ﹤0.01% |
18,190
-6,183
| -25% | -$267K |
2024 Q3
8 quarters
|
|
3543
Ambev
ABEV
$42.5B
| $611K | ﹤0.01% |
209,105
-543,041
| -72% | -$1.62M |
2013 Q4
51 quarters
|
|
3544
Grupo Aeroportuario del Sureste
ASR
$7.97B
| $610K | ﹤0.01% |
2,594
-162
| -6% | -$43K |
2016 Q3
40 quarters
|
|
3545
Schwab Short-Term US Treasury ETF
SCHO
$15.7B
| $609K | ﹤0.01% |
25,539
+414
| +2% | +$9.9K |
2014 Q4
47 quarters
|
|
3546
Collegium Pharmaceutical
COLL
$771M
| $608K | ﹤0.01% |
27,883
-15,794
| -36% | -$461K |
2015 Q2
45 quarters
|
|
3547
Alarm.com
ALRM
$3.34B
| $608K | ﹤0.01% |
11,164
-21,419
| -66% | -$1.17M |
2015 Q3
44 quarters
|
|
3548
iShares Systematic Bond ETF
SYSB
$1.41B
| $607K | ﹤0.01% |
7,207
+3,422
| +90% | +$298K |
2026 Q1
2 quarters
|
|
3549
Ginkgo Bioworks
DNA
$785M
| $607K | ﹤0.01% |
47,328
+1,502
| +3% | +$12.2K |
2021 Q4
19 quarters
|
|
3550
Olema Pharmaceuticals
OLMA
$660M
| $607K | ﹤0.01% |
70,270
-55,291
| -44% | -$602K |
2023 Q1
14 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.